What is the pathophysiology of the angiokeratomas and telangiectasias seen in FD, what is the typical distribution of these lesions—in male versus female patients—and with what other conditions might these be confused?

What is the pathophysiology of the angiokeratomas and telangiectasias seen in FD, what is the typical distribution of these lesions—in male versus female patients—and with what other conditions might these be confused?

What is the pathophysiology of the angiokeratomas and telangiectasias seen in FD, what is the typical distribution of these lesions—in male versus female patients—and with what other conditions might these be confused?


Created by

CMEducation Resources IQ&A Fabry Disease Diagnostic Intelligence Zone

Presenter

Paula Luna, MD

Paula Luna, MD

Director of the Fellowship on Psoriasis
and Other Inflammatory Disease
Hospital Aleman
Buenos Aires, Argentina